The Paxlovid pills are being developed at Pfizer’s two Irish plants in Ringaskiddy and Newbridge. Picture: Reuters
Pfizer’s new anti-viral drugs for Covid-19 will only be prescribed for “high-risk patients” for now, but may provide benefits to the wider public in time, according to the scientist who developed the treatment. Dr Annaliesa Anderson, the clinical development lead on the Paxlovid antiviral programme, was speaking to the Business Post from New Jersey in the US.Subscribe from just €1 for the first month!
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
New bill may push more legal costs on those who take insurers to court | Business PostRobert Troy: ‘If someone wants to reject their award and bring it to court and the court doesn’t increase the award any further, well then, they're going to have to pay for that’ obraonain now this is a good thing and will help
منبع: businessposthq - 🏆 8. / 71 ادامه مطلب »
Ronan to make new play for Dublin portfolio after legal case dropped | Business PostDeveloper may be seeking a new partner to bid for three landmark properties after ongoing dispute with US group Fortress is resolved out of court
منبع: businessposthq - 🏆 8. / 71 ادامه مطلب »
ESB’s new gas power contracts triple in value | Business PostWhistleblower has accused semi-state of abusing market position and ‘lowballing’ offers in earlier auctions
منبع: businessposthq - 🏆 8. / 71 ادامه مطلب »